Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Ambea acquires Danish care operations

Altiden, Ambea's Danish operations, acquires the care operations from EKKOfonden. EKKOfonden is one of Denmark's largest providers of social care for young people and adults.- We continue our strategy and grow in Denmark within a priority service area. EKKOfonden has a well-established operation with a good reputation with both care receivers and clients. Through the acquisition, we create conditions for continued growth and development within Altiden, says Benno Eliasson, acting CEO Ambea. EKKOfonden includes approx. 20 units and 170 beds all over Denmark. Revenue for 2019 was 250 MDKK.

Nordic Outlook: A world marked by setbacks and advances

Sweden: Fiscal stimulus will ease the burden on the Riksbank  COVID-19 vaccine roll-outs and powerful stimulus measures are laying the groundwork for a rapid recovery, once the pandemic releases its grip on the world economy. Despite the escalating spread of infection and expanded restrictions, late 2020 was not as weak as previously feared. The full-year 2020 decline in global GDP is expected to be only 3.7 per cent, compared to our November projection of 4.4 per cent. We have marginally downgraded our 2021 forecast to 5,0 per cent, while adjusting 2022 growth almost half a percentage

EQT AB (publ) Year-End Report 2020

Delivering on our strategy in a year of uncertaintyPlease note that all figures refer to continued operations, excluding Credit, unless stated otherwise HIGHLIGHTS FOR JAN-DEC 2020 (JAN-DEC 2019) · With a resilient portfolio, EQT’s focus on new thematic investment opportunities accelerated as market conditions improved. Total investments by the EQT funds in the period amounted to EUR 12.9bn (EUR 9.8bn) and total gross fund exits amounted to EUR 3.4bn (EUR 7.2bn) · AUM increased to EUR 52.5bn (EUR 36.0bn), primarily driven by the activation of EQT IX and EQT Infrastructure V

Transforming the track area into a new urban space in Liljeholmen

CITYCON OYJ   Corporate Press Release 26 January 2021 at 8:00 hrs The Nordic real estate company Citycon plans to develop residentials and offices at Liljeholmen by covering the track area at Liljeholmstorget. Under the name RE: Liljeholmen, an attractive living environment will be created with 120 new apartments, 3,000 workplaces and a glazed plaza with space for activities, cultural events and experiences. The project is being developed in collaboration with the City of Stockholm and the zoning phase will within a short time reach the consultation period. Citycon is already a

EQT continues to grow globally – joins forces with Exeter Property Group, creating a global leader in value-add real estate investing

EQT AB (publ) announces the signing of a combination (the “transaction”) with Exeter Property Group ("Exeter" which also includes funds), a leading global real estate investment manager with more than USD 10bn of assets under management ("AuM"). · Total consideration of USD 1,870m, comprising new EQT AB shares USD 800m and cash USD 1,070m (including refinancing of USD 300m of existing Exeter debt) · The combination accelerates EQT AB's strategic growth ambition within Real Estate, creating a scaled thematic investment platform with global reach · Transaction is consistent with

New neural network enables easy screening of sleep apnoea in patients with cerebrovascular disease

A new neural network developed by researchers at the University of Eastern Finland and Kuopio University Hospital enables an easy and accurate assessment of sleep apnoea severity in patients with cerebrovascular disease. The assessment is automated and based on a simple nocturnal pulse oximetry, making it possible to easily screen for sleep apnoea in stroke units. Up to 90% of patients experiencing a stroke have sleep apnoea, according to earlier studies conducted at Kuopio University Hospital. If left untreated, sleep apnoea can reduce the quality of life and rehabilitation of patients

7 years of uninterrupted growth takes global defence spend to USD1.9 trillion, says Janes

Rising at a rate of 1.9% in 2020, defence spending has enjoyed continuous growth since 2014 according to the latest figures from the trusted global agency for open-source defence intelligenceLONDON – Continuing seven years of uninterrupted expansion, global defence spending rose by 1.9% in 2020, according to defence spending data from Janes, the trusted global agency for open-source defence intelligence. Total global defence spending reached USD1.93 trillion* in 2020 – up almost USD180 billion from USD1.75 trillion in 2010. Global spending growth to slow in 2021, but no contraction

Acquisition of own shares / primary insider trades

On behalf of Gjensidige (OSE:GJF), DNB has on 25 January 2021 acquired 91 716 shares. The shares have been acquired at an average price of NOK 206,4141 per share. 58 649 shares have been sold to employees, at a price of NOK 206,4141 per share, as part of the Gjensidige share savings scheme 2020. Acquisition of shares for the share savings scheme for the fourth quarter 2020 is now completed. 18 829 shares have been allocated to executive personnel as variable pay. For a description of share-based payment to executive personnel, reference is made to note 22 in the annual report 2019.

Safeture carries out a directed share issue of approximately SEK 38.6 million

The board of directors of Safeture AB (”Safeture” or the ”Company”) has, pursuant to the authorization granted by the annual general meeting on 4 June 2020, resolved on a directed issue of approximately SEK 38.6 million before issue costs, comprising 4,600,000 new shares at a subscription price of SEK 8.40 per share (the “Directed Issue”). The Directed Issue is made to a limited number of selected investors, including Topline Capital Partners LP. The Directed Issue entails a dilution of approximately 15.3 per cent of the number of shares and votes in the Company. In connection with the

Chiquita Showcases The Nutritional Attributes of Its Tasty Yellow Bananas In All-New Sticker Series

Fort Lauderdale, FL –  Jan. 25, 2021 – Chiquita is continuing its mission of highlighting the fun side of healthy living in the new year by launching a new limited-edition Sticker Series focused on the benefits of Chiquita bananas, which will adorn millions of its bananas from the end of January through February. The transformed Blue Stickers feature a combination of essential vitamins and nutrients found in Chiquita bananas, along with playful sayings such as “Nature’s Candy Bar” and “Rush Hour Fuel” that showcase the versatility of the delicious fruit. The Ingredient Stickers are a

Q-Free: Acceptances received under mandatory offer to acquire all shares in Q-Free ASA

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the Offer, the distribution of this stock exchange announcement or the acceptance of any tender of shares would contravene applicable laws or regulations. (Oslo, 25 January 2021): Reference is made to the mandatory offer (the “Offer”) from Rieber & Søn AS (the “Offeror”) to acquire all shares in Q-Free ASA (“Q-Free” or the “Company”) pursuant to an offer document

European Commission Approves AbbVie’s RINVOQ [® ](Upadacitinib) ▼ for the Treatment of Psoriatic Arthritis and Ankylosing Spondylitis

· RINVOQ (15 mg, once daily) is the first oral, once-daily, selective and reversible JAK inhibitor approved for three adult rheumatic indications in the European Union: rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis[1,2] · Approval is supported by data from three pivotal clinical studies in psoriatic arthritis and ankylosing spondylitis where upadacitinib met all primary and key secondary endpoints with a safety profile consistent with that seen in rheumatoid arthritis[2-6] · Approvals underscore AbbVie’s longstanding commitment to deliver innovative medicines

SBB successfully issues EUR 600 million senior unsecured bond

Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) has today successfully issued a senior unsecured bond of EUR 600 million. The bond has a maturity of two years with a call option at par after approximately one year and carries a floating rate of 3 months EURIBOR plus 60 bps. The transaction targeted leading European money market accounts and fund managers and broadens SBB’s presence in the European capital markets further. The transaction was issued under the EMTN Programme and will be listed on Euronext Dublin. The proceeds will be used for general corporate purposes Deutsche Bank

#21-30 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-29 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Axolot Solutions will perform in-depth trials with the AxoPur® technology, with a customer in the food industry

Axolot Solutions has signed an additional trial agreement with a customer in the food industry.The trials with Axolot’s patented Axo-Pur technology will be carried out at the customer’s site, in February. This project is an in-depth continuation of the trials performed in December and aims among other things at providing a base for dimensioning a full-scale commercial system. The water should be purified from nutrients, fat and bacteria, in order to enable recirculation of the purified water and thereby decrease the water consumption and the total effluent volume. Martin Ragnar,

Ordinary General Meeting

Copenhagen, Denmark, 25 January 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby convenes an ordinary general meeting to be held on 9 February 2021To the shareholders of FluoGuide A/S The board of directors hereby convenes an ordinary general meeting of FluoGuide to be held on: Tuesday 9 February 2020 at 14:00 (CET) at the Company’s premises, Ole Maaløes Vej 3, room M4, DK-2200 Copenhagen N, Denmark. The agenda for the general meeting is as follows: 1. ELECTION OF CHAIRMAN OF THE MEETING 2. REPORT ON THE ACTIVITIES OF THE COMPANY IN THE PAST FINANCIAL YEAR 3.

Joint Study to Explore the Potential for Ammonia as a Marine Fuel in Singapore

ABS, Nanyang Technological University and the Ammonia Safety and Training Institute to Research Challenges and Opportunities(SINGAPORE) ABS, Nanyang Technological University (NTU), Singapore, and the Ammonia Safety and Training Institute (ASTI) are collaborating on a study of the potential of ammonia for Singapore, exploring supply, bunkering, and safety challenges with the marine fuel. Titled Ammonia as a Marine Fuel in Singapore – Supply Chain, Bunker Safety, and Potential Issues, the joint study will look at safety protocols and possible gaps in the supply chain of ammonia as a marine

Brighter has received the remaining approval for consumables related to Actiste Service in KSA

Brighter has now received the only remaining approval for consumables related to the Actiste Service from the Saudi Food and Drug Authority (SFDA) in the Kingdom of Saudi Arabia (KSA). The authorization process from the Communications and Information Technology Commission (CITC) for cellular connection is still ongoing. Before the service can be launched in KSA, Brighter will also have to finalize various internal and external go-to-market preparations, e.g. initiate relevant partnerships and ensure local data management compliance. For further background information, please see previous

Invitation to presentation of Bulten’s Q4 report 2020

Bulten’s full year report for the period January – December 2020 will be published on Thursday 11 February 2021 at approximately 13:30 CET.A presentation for analysts, media and investors will be held the same day at 15:30 CET. The report will be presented by Anders Nyström, President and CEO and Claes Lundqvist, acting CFO via audiocast. The presentation will be held in English and can be followed live via the link: https://tv.streamfabriken.com/bulten-q4-2020. It will also be possible to take part of the audiocast afterwards at the same address or at www.bulten.com/ir. To

2020 Bulkers Ltd. (2020) – Invitation to webcast and conference call Q4 2020 results

2020 Bulkers Ltd. will release its financial results for the fourth quarter of 2020 on Thursday, January 28, 2021. A conference call and webcast will be held at 3:00 PM CET. The earnings report and presentation will be available from the Investor Relations section on www.2020bulkers.com on the same day. In order to listen to the presentation, you may do one of the following: Listen-only webcast (including the slide presentation): https://edge.media-server.com/mmc/p/aswbvquw or you can click the “Webcast” link on www.2020bulkers.com/investor-relations/ Conference Call: Dial in

K-Fastigheter takes over the shares in Finja Prefab AB - creating a new business area

K-Fast Holding AB has today entered the acquisition of Finja Prefab AB and is now the legal owner of the company. Finja Prefab AB has been consolidated in the K-Fastigheter Group as of 1 January 2021, with operations reported under the “Prefab” business area from the same date. The press release of 1 December 2020 provided information about various long-term financing options. K-Fastigheter has now secured financing for the acquisition and operations through an acquisition loan of SEK 450 million through Handelsbanken, Finja Prefab’s existing main bank.“I am delighted to welcome Finja

Statement of the Shareholders’ Nomination Board of Ahlstrom-Munksjö Oyj

AHLSTROM-MUNKSJÖ OYJ  STOCK EXCHANGE RELEASE  JANUARY 25, 2021 at 15:30 EET SPA Holdings 3 Oy has on January 20, 2021 announced that it will complete the tender offer for the issued and outstanding shares in Ahlstrom-Munksjö Oyj commenced on October 22, 2020, in accordance with the terms and conditions thereof. On January 25, 2021, Ahlstrom-Munksjö Oyj has pursuant to its obligations under the Combination Agreement entered into with Spa Holdings 3 Oy issued a notice to convene an Extraordinary General Meeting to be held on February 19, 2021. The notice to convene the Extraordinary General

There are no items matching the current filter
There are no more items matching the current filter
Back to top